Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-root canal pain with 1.3% versus 5.25% sodium hypochlorite
IRCT20260606069669N1Phase 2Recruiting
- Sponsor
- Ilam University of Medical Sciences
- Start
- Oct 2026
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of sodium hypochlorite in irreversible pulpitis (2 arms), sponsored by Ilam University of Medical Sciences. Primary endpoints: Post-treatment pain at 48 hours and Analgesic consumption after treatment over 7 days. Started Oct 2026; status: recruiting.
02
Drugs
sodium hypochlorite
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on IRCT20260606069669N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260606069669N1.